e-z cinnamic acid has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, S; Gamit, N; Mandal, S; Rao, CM; Sethi, G; Warrier, S | 1 |
| Andrysiak, K; Dulak, J; Gunia-Krzyżak, A; Klaś, K; Koczurkiewicz-Adamczyk, P; Lasota, S; Madeja, Z; Pękala, E; Piska, K; Stępniewski, J; Wójcik-Pszczoła, K | 1 |
2 other study(ies) available for e-z cinnamic acid and Cardiotoxicity
| Article | Year |
|---|---|
An efficient human stem cells derived cardiotoxicity testing platform for testing oncotherapeutic analogues of quercetin and cinnamic acid.
Topics: Cardiotoxicity; Doxorubicin; Humans; Induced Pluripotent Stem Cells; Mesenchymal Stem Cells; Myocytes, Cardiac; Quercetin | 2022 |
Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin.
Topics: Animals; Cardiotonic Agents; Cardiotoxicity; Cinnamates; Doxorubicin; Hep G2 Cells; Humans; Myocytes, Cardiac; Oxidative Stress; Rats | 2021 |